Latest Breaking News On - Increasing serum potassium - Page 3 : comparemela.com

Travere Therapeutics Announces Late-Breaking Data from Phase 3 Studies of Sparsentan in IgAN and FSGS Published in The Lancet and The NEJM Respectively and Presented at the American Society of Nephrology (ASN) Kidney Week 2023

Two-year results from both PROTECT and DUPLEX pivotal Phase 3 studies demonstrate treatment with sparsentan has the potential to preserve kidney function and significantly delay time to kidney.

United statesMichellen rheaultBrad rovinNivi nehraNaomi eichenbaumJula inrigOhio state university centerDivision for nephrologyTravere therapeutics incAmerican society of nephrologyDivision of pediatric nephrologyExchange commissionCorporate communicationsClinical research managementUniversity of minnesota medical schoolAmerican society

Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023

Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesNaomi eichenbaumJula inrigNivi nehraCorporate communicationsAmerican society of nephrologyExchange commissionTravere therapeutics incUniversity of leicester studyTravere therapeuticsAmerican societyKidney weekFocal segmental glomerulosclerosisAbstract sessionHigh impact clinical

Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023

Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomJula inrigNaomi eichenbaumNivi nehraAmerican society of nephrologyCorporate communicationsTravere therapeutics incExchange commissionUniversity of leicester studyAmerican societyKidney weekFocal segmental glomerulosclerosisAbstract sessionHigh impact clinicalPediatric patients

Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023

Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomNivi nehraJula inrigNaomi eichenbaumUniversity of leicester studyCorporate communicationsTravere therapeutics incAmerican society of nephrologyExchange commissionAmerican societyKidney weekFocal segmental glomerulosclerosisAbstract sessionHigh impact clinicalPediatric patients

Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023

Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesNivi nehraJula inrigNaomi eichenbaumExchange commissionCorporate communicationsUniversity of leicester studyAmerican society of nephrologyTravere therapeutics incPresent abstractsAmerican societyKidney weekFocal segmental glomerulosclerosisAbstract sessionHigh impact clinical